Dr Daniel Peshka, DO | |
143 Sunrise Dr, Holland, MI 49423-6600 | |
(616) 402-3994 | |
Not Available |
Full Name | Dr Daniel Peshka |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 143 Sunrise Dr, Holland, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073560181 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | CDR.0003047 (Colorado) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 5101009901 (Michigan) | Primary |
Entity Name | Mclaren Bay Region |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508131087 PECOS PAC ID: 5597659011 Enrollment ID: O20040213000277 |
News Archive
Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center.
Researchers have discovered a factor that controls blood sugar's manufacture in a novel way: by limiting the supply of its building blocks. The findings are reported in the April issue of the journal Cell Metabolism, published by Cell Press.
New detection methods could shorten the detection of sepsis from days down to only a few hours. Sepsis is a possibly mortal bacterial infection. It affects neonates and young infants more severely since their immune system is not fully developed. Now scientists are developing a fully automated system, which can identify sepsis in infants within hours instead of days.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
AMN Healthcare Services, Inc., the nation's leader and innovator in healthcare workforce solutions and staffing services, today announced the completion of the acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for a total purchase price of $82.5 million.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Peshka, DO 143 Sunrise Dr, Holland, MI 49423-6600 Ph: (616) 402-3994 | Dr Daniel Peshka, DO 143 Sunrise Dr, Holland, MI 49423-6600 Ph: (616) 402-3994 |
News Archive
Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center.
Researchers have discovered a factor that controls blood sugar's manufacture in a novel way: by limiting the supply of its building blocks. The findings are reported in the April issue of the journal Cell Metabolism, published by Cell Press.
New detection methods could shorten the detection of sepsis from days down to only a few hours. Sepsis is a possibly mortal bacterial infection. It affects neonates and young infants more severely since their immune system is not fully developed. Now scientists are developing a fully automated system, which can identify sepsis in infants within hours instead of days.
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world's 20 leading pharmaceutical companies. Boehringer Ingelheim's business areas include Prescription Medicines, Consumer Health Care and Biopharmaceuticals, as well as Pharma Chemicals and Animal Health.
AMN Healthcare Services, Inc., the nation's leader and innovator in healthcare workforce solutions and staffing services, today announced the completion of the acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for a total purchase price of $82.5 million.
› Verified 6 days ago
Dr. Marcel Michael Letourneau, D.O Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 602 Michigan Ave Ste 102, Holland, MI 49423 Phone: 616-494-8724 | |
Tricia R Miller, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 437 North 120th Ave, Holland, MI 49424 Phone: 616-738-0737 | |
Timothy Conlon, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3235 N Wellness Dr, Building A Suite 120b, Holland, MI 49424 Phone: 616-399-9522 | |
Dr. Karl Nadolsky Jr., DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 904 Washington Ave Ste 210, Holland, MI 49423 Phone: 616-395-2833 | |
Brian Drozdowski, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 437 120th Ave, Holland, MI 49424 Phone: 616-738-0737 | |
Matthew Steinberger, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 602 Michigan Ave, Holland, MI 49423 Phone: 616-546-4950 Fax: 616-546-4955 |